Accomplished postdoctoral fellow specializing in pediatric oncology with a strong background in chemoresistance and oncogenic drivers in solid tumors. Investigated the role of protein phosphatase 2A (PP2A) in pediatric cancers, demonstrating therapeutic potential through novel small molecule activators. Focused on elucidating molecular and epigenetic factors contributing to disease relapse and developing preclinical evidence for PP2A reactivation strategies. Dedicated to bridging research and clinical practice to improve treatment options and quality of life for patients with solid tumors.